STOK
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. (STOK) has 9 SEC Form 4 filings (39 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 6, 2026.
The most active filer is CHIEF MEDICAL OFFICER Ticho Barry with 8 filings. Insiders have net sold $1.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Ian F. Smith
- Employees:128
- HQ:Bedford, MA, US
- IPO:2019-06-19
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$1.8B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Ticho BarryFirst in 4 months | CHIEF MEDICAL OFFICER | Sale | 7,228 | $236K | Jul 6 | SEC ↗ |
Allan JonathanFirst filing | GENERAL COUNSEL & CORP SEC | Sale | 1,457 | $44K | Jun 18 | SEC ↗ |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 6,164 | $203K | Mar 19 | SEC ↗ |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 6,686 | $210K | Mar 19 | SEC ↗ |
Ticho BarryFirst in 3 months | CHIEF MEDICAL OFFICER | Sale | 1,461 | $44K | Mar 19 | SEC ↗ |
Leggett ThomasFirst filing | Chief Financial Officer | Sale | 2,196 | $72K | Mar 19 | SEC ↗ |
Leggett ThomasFirst filing | Chief Financial Officer | Sale | 2,382 | $75K | Mar 19 | SEC ↗ |
Hoitt JasonFirst filing | Chief Patient Officer | Sale | 1,781 | $59K | Mar 19 | SEC ↗ |
Hoitt JasonFirst filing | Chief Patient Officer | Sale | 1,931 | $61K | Mar 19 | SEC ↗ |
Kaye Edward M. MDFirst filing | Insider | Sale | 6,453 | $199K | Dec 5 | SEC ↗ |
Kaye Edward M. MDFirst filing | Insider | Sale | 8,548 | $268K | Dec 5 | SEC ↗ |
| CHIEF MEDICAL OFFICER | Sale | 1,696 | $52K | Dec 5 | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 3,662 | $115K | Dec 5 | SEC ↗ | |
Ticho BarryFirst filing | CHIEF MEDICAL OFFICER | Sale | 2,006 | $60K | Dec 3 | SEC ↗ |
Ticho BarryFirst filing | CHIEF MEDICAL OFFICER | Sale | 2,014 | $62K | Dec 3 | SEC ↗ |
Related companies
Stoke Therapeutics, Inc. is in the Healthcare sector.